Evidence map›Paper›PMID 27182271›Full record

ReviewPakistan journal of medical sciences

Diabetic Macular Edema.

Fatih C Gundogan, Umit Yolcu, Fahrettin Akay, Abdullah Ilhan, Gokhan Ozge, Salih Uzun

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Pakistan journal of medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05542381 (The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05542381 nacompletednot on this map

The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain

TypeinterventionalSponsorVirginia Polytechnic Institute and State UniversityRan2022 to 2025Enrolled64ConditionsAge-Related Macular DegenerationArmsLoteprednol Etabonate Ophthalmic Gel [Lotemax], Refresh Lubricant Eye Drops [Artificial Tears]
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. One-Year Effectiveness Study of Intravitreously Administered ConberceptDiabetes therapy : research, treatment and education of diabetes and related disorders · 2020
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Spotlight on fundus autofluorescence.Clinical optometry · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 3 countries.

Fatih C GundoganFatih C. Gundogan, GATA Medical School, Ophthalmology, Ankara, Turkey.
Umit YolcuUmit Yolcu, Sarikamis Military Hospital, Ophthalmology, Kars, Turkey.
Fahrettin AkayFahrettin Akay, İzmir Military Hospital, Ophthalmology, Izmir, Turkey.
Abdullah IlhanAbdullah Ilhan, Erzurum Military Hospital, Ophthalmology, Erzurum, Turkey.
Gokhan OzgeGokhan Ozge, GATA Medical School, Ophthalmology, Ankara, Turkey.
Salih UzunSalih Uzun Etimesgut Military Hospital, Ophthalmology, Ankara, Turkey.
Erzurum Regional Training and Research Hospital · TREtimesgut Asker Hastanesi · TRFatih University · TRGülhane Askerî Tıp Akademisi · TRMilitary Hospital · PKRwanda Military Hospital · RW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic macular edema (DME), one the most prevalent causes of visual loss in industrialized countries, may be diagnosed at any stage of diabetic retinopathy. The diagnosis, treatment, and follow up of DME have become straightforward with recent developments in fundus imaging, such as optical coherence tomography. Laser photocoagulation, intravitreal injections, and pars plana vitrectomy surgery are the current treatment modalities; however, the positive effects of currently available intravitreally injected agents are temporary. At this point, further treatment choices are needed for a permanent effect. SOURCES OF DATA SELECTION: The articles published between 1985-2015 years on major databases were searched and most appropriate 40 papers were used to write this review article.

Indexed as

BevacizumabDiabetic macular edemaFluorescein angiographyOptical coherence tomographyPars plana vitrectomyRanibizumabTriamcinolone acetonide

Identifiers

PMID27182271
PMCPMC4859054
OpenAlexW2430558590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.